There are little data on antiretroviral therapy (ART) adherence among patients in Eastern Europe, despite the high incidence of HIV infection and the growing number of HIV-infected individuals who are being prescribed ART. The aim of this study was to measure rates of adherence to ART and factors associated with nonadherence among patients receiving care at an outpatient HIV clinic in Estonia. The study was based on cross-sectional data from a convenience sample of 144 patients receiving outpatient HIV care. Data were obtained via intervieweradministered surveys and data abstraction from clinical records. Adherence was measured from a 3-day patient self-report. Among 144 participants (mean age 33.8 years), two-thirds (63%) had been infected with HIV through intravenous drug use. Most (74%) were co-infected with hepatitis C (HCV). Perfect adherence over the last 3 days was commonly reported (88% [95% CI 81Á92%]) with nonperfect adherence associated with greater concerns about the potential adverse consequences of taking ART (adjusted odds ratio [AOR] 4.8, 95% CI 1.2Á34.0) and average (versus good/very good) self-reported health status (AOR 4.7, 95% CI 1.2Á31.4). Self-reported ART adherence in this sample of Estonian HIV-positive patients in clinical care was similar to rates observed in Western Europe and other developed countries. Results suggest that adherence education and support may be most helpful if they specifically target the development of positive beliefs, reduction of negative expectancies towards ART.
Introduction
Highly active antiretroviral therapy (ART) has improved the health and quality of life of people living with HIV (PLWH) since its introduction in the late 1990s (Bhaskaran et al., 2008; Hamers & Downs, 2004) . Further, evidence from mathematical modeling analyses, observational studies, and recent randomized controlled studies support the potential role of ART as a HIV prevention tool (Cohen et al., 2011) .
The potential benefits of ART to individual health are well established (Bangsberg, Hecht, Charlebois, Chesney, & Moss, 2001; Garcia de Olalla et al., 2002; Hogg et al., 2002) . However, even the more simplified ART regimens currently available can be burdensome and pose difficulties for sustained high rates of adherence over time, which is critical in the prevention of drug-resistance (Bangsberg, 2006; Maggiolo et al., 2005) . Nonadherence has received considerable attention in last decade yet continues to be ubiquitous (Chesney, 2003) . Medication adherence is a complex behavior, influenced by multiple determinants belonging to different domains: the patient, the treatment, the disease state, the physician and patientÁphysician relationship, and the healthcare system (Ammassari et al., 2002) .
Despite international research efforts to examine ART adherence in diverse populations, there is limited information currently available concerning ART adherence and factors influencing it in Eastern Europe. In 2009, Estonia had one of the highest rate of newly diagnosed HIV cases (27.8 per 100,000 inhabitants) (European Centre for Disease Prevention and Control [ECDC] , 2011), and estimated HIV prevalence of 1.2% among adults aged 15Á49 (UN-AIDS, 2011) in the European region. It has been estimated that there are about 11,000 PLWH in Estonia where the HIV/AIDS epidemics have been mainly concentrated among injection drug users (IDUs) (Lai et al., 2009 ). According to local HIV treatment guidelines, ART should be initiated for all patients with a CD4 count B350 cells/mm 3 or with a history of an AIDS-defining illness (European AIDS Clinical Society [EACS], 2010) . Health insurance in Estonia is funded through a compulsory scheme under which employers are obliged by law to pay social and health insurance taxes for their employees. In addition, there is a list of persons for whom no social tax is paid but who are considered as having equal status to the insured person (i.e., pregnant women, persons under HIV care, including ART, is provided by Estonia's national healthcare system free of charge, and delivered through outpatient HIV clinics that are run by infectious disease departments in five major hospitals. However, for those uninsured, free care is limited to treatment of HIV and does not include other health problems, such as hepatitis C treatment. Despite the availability of ART, the rate of uptake needed to manage individual and community-level HIV burden has been insufficient, with only 1793 patients of an estimated 11,000 individuals living with HIV receiving ART at the end of 2010 (UNODC/ WHO, 2011). Once initiated, ART is often prescribed with limited ongoing monitoring or support for ART adherence. The adherence support offered by the HIV clinics is frequently restricted to information provision and insistence on near-perfect adherence by the treating physician. While support for enhancing ART adherence is a growing area of interest amongst treatment providers, there are currently little data available to guide such efforts, in Estonia specifically but also more broadly among patients in Eastern Europe. The state of the literature is presently poorly prepared to guide efforts to support the growing numbers of HIV-infected patients who are being prescribed ART in Eastern Europe.
The objective of the current study was to begin to bridge this gap in the literature by characterizing ART adherence and factors associated with it among patients in care at an outpatient HIV clinic in northeastern Estonia, an area with a high prevalence of HIV infection.
Methods

Setting and sample
Between July 2010 and December 2010, a convenience sample of 161 consecutive consenting patients presenting for routine HIV clinical care visits at the Infectious Diseases Department of the East-Viru Central Hospital in Estonia was enrolled. In 2010, this department provided HIV care to 651 patients, of whom 372 were receiving ART at the time of the study (JulyÁDecember 2010). The hospital is staffed by three infectious diseases-trained physician and eight nurses. In addition, part-time social worker/ case manager is working at the clinic. Inclusion criteria for the study were aged over 18 years, ability to read and write in Estonian or Russian, and receiving ART.
After determining eligibility and securing informed consent, a structured interviewer-delivered questionnaire was administered by a trained nurse taking approximately 45Á60 minutes to complete. These interviews were conducted in a private location in the clinic following the participant's medical visit.
Medical data were abstracted from clinical records by the study physicians using a standardized data abstraction form. Participants received a supermarket voucher with a value of 6.40 EUR as an incentive for study participation.
The Ethics Review Board at the University of Tartu approved all study procedures.
Measures
Data collected for interview included demographic characteristics (such as age, sex, and ethnicity), living conditions, main source of income, sexual history including sexual risk-taking behaviors, education level, housing, HIV testing and healthcare utilization history. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression scale (CES-D), a 20-item self-report scale which measures the current level of depressive symptomatology, with an emphasis on depressed mood during the past week (Radloff, 1977) . CES-D scores of 16Á26 are considered indicative of mild depression while scores of 27 or more indicate major depression (Radloff, 1977) . Zich et al. found the stringent cut-off score of 27 more useful for screening medical patients for depression than the standard cut-off score of 16 (Zich, Attkisson, & Greenfield, 1990) . Self-rated health status was assessed with a five-item measure (Eriksson, Unde´n, & Elofsson, 2001) . Substance abuse behaviors assessed included history of drug use, route of administration, and drug abuse treatment history (methadone substitution therapy). Substance abuse severity was measured by the Drug Abuse Screening Test-10 (DAST-10) (Skinner, 1982) , which is a brief version of the 28-item DAST designed to identify drug use-related problems in the previous year. The alcohol use disorders identification test (AUDIT), a 10-item interview, was used to identify individuals AIDS Care 1471 with hazardous and harmful patterns of alcohol consumption (Saunders, Aasland, Babor, de la Fuente, & Grant, 1993) .
Adherence was assessed via a 3-day recall of doses missed (Chesney et al., 2000) . The association between this measure and virologic and immunologic outcomes has been demonstrated in several studies (Mannheimer et al., 2006 (Mannheimer et al., , 2008 Simoni et al., 2006) . Rates of adherence were calculated as the proportion of doses taken in full, as prescribed, for all medications in an individual's regimen relative to total doses prescribed during that time period (total doses taken in full as prescribed over total doses prescribed during the past 3 days). Additionally, participants were assessed on regimen knowledge via questions about their medication name(s), dose requirements, and frequency of dosing.
Perceptions of ART were assessed using the Beliefs about Medicine Questionnaire-ART specific version (BMQ-HAART), which has been validated among PLWH Horne, Cooper, Gellaitry, Date, & Fisher, 2007) . The BMQ-HAART produces two scales (beliefs about the necessity of ART and concerns about the potential adverse consequences of taking ART), ranging from 1 to 5 as summed scale scores with higher scores reflecting greater endorsement of necessity and concerns about the potential adverse effects of the treatment .
Additional variables included in the analysis were self-reported health insurance status (as a proxy indicator for access to health care in general) and self-rated health (as a subjective assessment of one's health status and related practices).
Data abstracted from the clinical records included: ART regimen prescribed, duration of ART, co-infections such as hepatitis C virus (HCV), CD4' cell counts, and HIV-1 RNA detection (viral load) with a sensitivity of 50 copies/ml.
Statistical analysis
Successful long-term treatment of HIV/AIDS requires at least 95% adherence to ART in order to prevent emergence of drug-resistant HIV variants that lead to regimen failure and limit future therapeutic options (Maggiolo et al., 2005) . Given that the adherence measure used in a study (3-day recall) will not give information on long-term adherence, the rate of self-reported adherence was dichotomized as 100% (perfect adherence) vs. B100% (nonadherent) and nonadherence as a primary outcome in the analysis to be more conservative in the assessment.
Socio-demographic, substance abuse, and other factors were compared between the adherent and the nonadherent group. Correlates of adherence were explored using the Fisher's exact test and Wilcoxon rank sum test; crude odds ratios of nonadherence were calculated. Logistic regression was used to estimate adjusted odds ratios. We adjusted for factors associated in bivariate analyses with adherence at significance levels of 0.1 or lower and not considered as outcomes of adherence.
Results
Sample characteristics
Among 161 participants, a small subset of the sample was just starting ART (10.6%, n 017). Among those initiating ART the mean CD4 count was 220 (SD 71) cells/mm 3 . Given that the adherence assessment relies on actual experience with ART, these 17 participants were excluded from further analyses. Participants retained for the analysis (n 0144) did not differ from those initiating ART in terms of age (median 32 vs. 29 years, p00.09), gender (male proportion 55% vs. 59%, p00.8), risk factor for HIV (IDU: 63% vs. 75%, p00.4) or the duration on HIV infection (median: 5 years in both groups, p 00.5). Among those retained for the analysis (N 0144), there were 79 men (55%) and 65 women (45%). They ranged in age from 19 to 77 years (mean 33.8, SD 8.23). Over half of them were either married (26.6%) or living with a sexual partner (28.7%). Two-thirds (70%) of participants had completed more than 9 years of education. Most (73%) were unemployed and lived on social benefits (53%) or income from relatives/partner (20%). The vast majority (91%) were covered by Estonian state health insurance.
Based on self-reported first positive HIV test, on average these 144 patients had been diagnosed with HIV for 5.6 years (SD 3.49). Two-thirds (63%) had been infected with HIV through intravenous drug use (82.9% of men, 39.1% of women). One-third of those 144 participants reported illicit drug use within the preceding year. The majority (74%) were co-infected with HCV. One-third of the patients on ART reported signs of clinically significant depression. The study subjects had been on ART for an average of 1.5 years (SD 1.5). The mean CD4 count was 355 cells/mm 3 (SD 225 cells/mm 3 ). However, a quarter of the sample (26%) had a CD4 count below 200 cells/ mm 3 . Viral load was undetectable for 56% (N 080). Eighty-eight percent [95% CI 81Á92%] of participants reported 100% adherence over the past 3 days. Using a cut-off of 95% adherence did not change results (data not shown).
Bivariate analysis
As indicated in Table 1 , those with higher CD4 counts were less likely to be nonadherent ( ]350' cells/mm 3 OR 0.20, 95% CI 0.03Á0.93). Those with detectable viral load were more likely to be nonadherent (OR 5.3, 95% CI 1.5Á23.2). Medication nonadherence was not associated with the concurrent morbidities assessed (depression, alcohol, and drug use) or ART regimen factors (number of pills and dosing frequency). No differences were found in adherence between those reporting ever having been an IDU and nonIDUs; and between IDUs currently either on methadone or not on methadone.
Multivariate analysis
As indicated in Table 1 (far right column), insurance status and self-rated health were adjusted for in the multivariate analysis. Study participants who exhibited greater concerns about perceived negative consequences of taking ART had five times the odds of being nonadherent than those with lower concerns (adjusted odds ratio [AOR] 4.8, 95% CI 1.2Á34.0). Participants who self-rated their health as average, as opposed to good/very good, had higher odds for nonadherence (AOR 4.7, 95% CI 1.2Á31.4).
Viral load (AOR 3.9 95% CI 1.25Á14.73) remained significantly associated with nonadherence and rather than predictor can be interpreted as outcome of (non) adherence.
Logistic regression models were used for calculating adjusted odds ratios. In all cases, generalized variance inflation factor (VIF) was lower than 5 for all independent variables, having maximum value of 1.20 for self-rated health when calculating adjusted odds ratio for main source of income (Dobson & Barnett, 2008 ).
Discussion
Self-reported ART adherence in this sample of Estonian HIV-positive patients in clinical care was similar to the rates currently observed in other developed countries, with the majority reporting very high rates of adherence (88% of the sample). Other studies using 3-day self-report recall have reported similarly large numbers of participants classified as high adherers, with rates ranging from 84% to 97% among vulnerable populations such as AIDS Care 1475 marginally housed and drug using adults (Amico, Toro-Alfonso, & Fisher, 2005; Giordano, Guzman, Clark, Charlebois, & Bangsberg, 2004; Oyugi et al., 2004; Walsh & Sherr, 2002) . Perceived barriers to ART include beliefs about the need for treatment and concerns about adverse effects. Our results associating nonadherence with higher ART concerns are in line with other studies where nonadherence has been linked to health beliefs (Cooper et al., 2011) , concerns about side effects (Johnson et al., 2011) and long-term toxicities, scheduling demands and personal capacity to adhere, concerns about the impact of HAART on selfidentity, and the possibility that taking treatment might lead to disclosure of the individual's HIV status (Gonzalez et al., 2007) .
Global self-evaluations of health (measured by self-rated health) have proven to be sensitive predictors of mortality (Benyamini & Leventhal, 1999) , morbidity (Dominick, Ahern, Gold, & Heller, 2002) , and hospitalization (Kennedy, Kasl, & Vaccarino, 2001) . Few studies have also assessed its association with ART adherence and derived conflicting results: either lower self-rated health being protective against (Christofides et al., 2006) or risk factor (Cardarelli et al., 2008) for nonadherence. In our analysis general health status was similarly found to be a unique significant predictor of ART nonadherence (those with participants rating their health as less than very good or good were more likely to be nonadherent). Research findings suggest that self-rated health is not only a spontaneous assessment of one's health status and related practices; like a self-concept, self-rated health may be regulated by efforts to achieve one's relatively important health-related goals (Bailis, Segall, & Chipperfield, 2003) .
Less than perfect adherence was reported more commonly among those reporting drug use within the past 12 months compared to nonusers (24% vs. 7%, p00.2), which was also the case for those reporting ever injecting drugs compared to their counterparts (15% vs. 8%, p00.3). Neither difference was significant, suggesting that in our sample active or historical IDU was not predictive of nonadherence. These null findings for a relation between adherence and drug use are consistent with emerging work in this area (Carrieri et al., 2003; Malta, Magnanini, Strathdee, & Bastos, 2010) and the call to offer ART to drug users (Volkow & Montaner, 2011) .
Similarly, in this cohort alcohol use was not identified as an influential factor on ART adherence. However, it is important to note that several studies from this region have described hazardous and harmful alcohol consumption patterns contributing to ill health and mortality (Norstro¨m, 2011; Pa¨rna & Rahu, 2010) . Further examination of the extent to which alcohol use may exert influence on adherence is needed.
Our study has several limitations. The crosssectional study design does not allow us to evaluate directional or causal relationships. Second, we used a nonprobability sample that may have implications for the representativeness and generalizability of our study findings. The Infectious Diseases Department of the East-Viru Central Hospital served 21% of all HIV-infected patients receiving care in Estonia in 2010. Based on the data available, the patients on ART in this clinic did not differ from the other HIVinfected patients in care in Estonia in terms of gender or health insurance status. There were some differences in age, with those in our study being older (B24 years: 3% vs. 12%, pB0.01) and in the International Classification of Diseases 10 (ICD-10) diagnosis profiles with patients from East-Viru Central Hospital being more frequently diagnosed with HIV disease resulting in infectious and parasitic diseases (B20, ICD-10) than for patients in Estonia in general (7% vs. 23%, p B0.01) (data not shown) (personal communication: Reili Kaber, Estonian health insurance fund, 26 June 2011). Third, our sample size is small, proportion reporting nonperfect adherence is comparatively small, and thus some of our measures of association may lack statistical significance simply due to insufficient power or cell sparcity. While appropriate statistical methods were adopted to account for low cell counts, generalizability to larger populations of nonadherent individuals who may in fact be completely out of care or only infrequent attendees to clinical care is clearly limited.
Finally, we used a self-reported recall method for adherence measurement which is prone to recall and social desirability biases. Literature suggests that patients tend to overestimate adherence when the adherence is measured by patients' self-report (Chesney et al., 2000) . Recall bias may have been mitigated by the 3-day recall measure that has been used consistently in the ART adherence literature, was relatively ''short'' in length of recalls, and demonstrated anticipated associations with immune functioning measures. Despite efforts to minimize potential social desirability bias, including using interviewers who were not treating physicians and training all study staff in methods to ensure client confidentiality, and in approaches to promote respondent belief in the confidentiality of their selfreports, we suspect some over-reporting of adherence in this cohort particularly given that 77% of those with detectable viremia also reported perfect 3-day adherence. Nevertheless, structural self-report has been associated with objective measures of adherence and with viral load. We found that viral load was associated with self-reported perfect/imperfect adherence, providing additional confidence in the selfreport measure we used.
With these limitations in mind, the current results do provide the much needed exploration of factors that influence ART adherence among PLWH in Estonia. Future research should seek to evaluate these factors longitudinally to begin to disentangle which factors predict nonadherence and which may be co-occurring or the result of nonadherence. Our results discussed about cross-sectional associations, or correlates. The extent to which factors identified can be influenced through targeted intervention and if change in these factors influence change in adherence is the focus of our ongoing program of research collaborations with HIVcare providers and patient populations in Estonia.
Conclusions
Among Estonian HIV-infected patients in an area with a high prevalence of IDU, self-reported ART adherence rates are high although viral suppression is low. Adherence was associated with virologic and immunologic HIV disease markers, as well as factors such as health care, perceived health status, number of ARVs, and beliefs about the consequences of ART adherence. Nonadherence was not differentially higher among IDUs or those reporting high rates of alcohol use. Adherence support programs or approaches may be most effective if they target beliefs about antiretroviral treatment efficacy, concerns about side effects and long-term toxicities.
